Shorla Oncology & EVERSANA announce U.S. commercial launch of FDA-Approved JYLAMVO, the first and only oral methotrexate solution approved in the U.S. for adults
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, and EVERSANA®, a leading provider of commercialization services to the life science industry, today announced the commercial launch of JYLAMVO (methotrexate) oral solution, the first and only oral methotrexate solution approved in the United States for use in adults. JYLAMVO has been shown to have a sweet, palatable taste 1,2*and is approved …